Takeda Pharmaceutical Company Limited TAK

$ 18.22 2.53%

Quarterly report 2022-Q1
added 06-29-2022

Takeda Pharmaceutical Company Limited DPO Ratio 2011-2026 | TAK

Annual DPO Ratio Takeda Pharmaceutical Company Limited

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	70.9	117	177	157	130	120	138	96.8	83	243

All numbers in JPY currency

Indicator range from annual reports

Maximum	Minimum	Average
243	70.9	133

DPO Ratio of other stocks in the Biotechnology industry

	Issuer	DPO Ratio	Price	% 24h	Market Cap	Country
	Acorda Therapeutics ACOR	277	-	-24.86 %	$ 820 K	USA
	Acasti Pharma ACST	4.39 K	-	4.01 %	$ 150 M	Canada
	Advaxis ADXS	143 K	-	-9.65 %	$ 45.9 M	USA
	I-Mab IMAB	2.24 K	-	-	$ 866 M	China
	AgeX Therapeutics AGE	9.04 K	-	-10.17 %	$ 12.2 K	USA
	Aptorum Group Limited APM	405	$ 0.79	-0.79 %	$ 4.31 M	China
	Alexion Pharmaceuticals, Inc. ALXN	78.2	-	-	$ 40.3 B	USA
	Albireo Pharma ALBO	1.59 K	-	-0.23 %	$ 916 M	USA
	Midatech Pharma plc MTP	162	-	-18.52 %	$ 27.3 M	Britain
	Институт стволовых клеток человека ISKJ	115	-	-	-	Russia
	Aeterna Zentaris AEZS	34.4 K	-	5.93 %	$ 314 M	Canada
	Anika Therapeutics ANIK	54.4	$ 14.36	1.13 %	$ 210 M	USA
	AVEO Pharmaceuticals AVEO	235	-	-	$ 521 M	USA
	Ayala Pharmaceuticals AYLA	2.21 K	-	-	$ 7.46 M	Israel
	Aytu BioScience AYTU	186	$ 2.64	3.94 %	$ 16.6 M	USA
	BioCardia BCDA	68.1 K	$ 1.27	0.79 %	$ 26.9 M	USA
	AstraZeneca PLC AZN	265	-	-	$ 96.9 B	Britain